Ideas to Action:

Independent research for global prosperity

Publications

 

An image of a Covid-19 vaccine
June 4, 2020

India’s COVID-19 Testing Capacity Must Grow by a Factor of 10: Here’s How That Can Happen

Diagnostic testing is at the center of the policy debate around COVID-19 interventions in India. As of June 1, 2020, India had conducted approximately 3.8 million tests since it began testing in February, but many experts have noted that testing capacity is still drastically insufficient for the needs of the population.

Prashant Yadav , Abha Mehndiratta , Kalipso Chalkidou , Sidharth Rupani and Krishna Reddy
Vaccine manufacturing plant. Adobe Stock
April 25, 2020

Delivering on the Promise of “Equitable Access” to Epidemic Vaccines and Treatments: the Need for Norms, Processes, and Evidence to Guide Supply and Allocation

While there has been much interest and investment in developing epidemic vaccines and medicines to combat emerging infectious disease threats, there has been less attention to how we will manage and allocate the global supply of efficacious vaccines and treatments once we have them. The launch of the Access to COVID-19 Tools (ACT) Accelerator marks an unprecedented commitment to global collaboration to ensure rapid and equitable access to medical countermeasures for COVID-19, such as vaccines and treatments.